Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term

According to Zacks, Ensign Group (ENSG), a healthcare services provider, is a compelling growth stock, holding a Zacks Rank #2 (Buy) and a VGM Score of B. The company's Growth Style Score of B is supported by a projected 14.4% year-over-year earnings growth for the current fiscal year, and the consensus EPS estimate for fiscal 2025 has increased by $0.05 to $6.29 following upward revisions by three analysts in the last 60 days.

Analysis

The Ensign Group (ENSG), a healthcare services provider specializing in the post-acute care continuum, urgent care, and mobile ancillary businesses, is highlighted by Zacks as a strong candidate for growth-oriented investors. The company currently holds a Zacks Rank #2 (Buy), indicating a positive outlook based on earnings estimate revisions. This is further supported by a VGM Score of B, suggesting a favorable combination of value, growth, and momentum, and a specific Growth Style Score of B. ENSG is forecasted to achieve a substantial 14.4% year-over-year earnings growth for the current fiscal year. Analyst sentiment for fiscal 2025 appears to be improving, as evidenced by three upward earnings estimate revisions within the last 60 days, which has contributed to an increase in the Zacks Consensus Estimate by $0.05 to $6.29 per share. Additionally, ENSG has demonstrated a consistent ability to surpass earnings expectations, boasting an average earnings surprise of 1.6%. According to the Zacks framework, the combination of a #2 Rank with B-rated Style Scores signifies a heightened probability of the stock outperforming the broader market.

Key Decisions for Investors

• Given ENSG's Zacks Rank #2 (Buy), favorable Growth and VGM Style Scores of B, and positive earnings estimate revisions, investors with a growth-focused strategy should consider this stock for further evaluation.
• The projected 14.4% year-over-year earnings growth for the current fiscal year, along with the upward revisions to fiscal 2025 earnings estimates, provides a constructive outlook, meriting close attention to future earnings releases and analyst sentiment shifts.
• ENSG's demonstrated history of delivering an average earnings surprise of 1.6% points to operational efficacy and could justify its inclusion on a shortlist for investors seeking exposure to the healthcare services sector with a growth tilt.